Full-Time
Care Navigator
Concierge Medicine
Brown University Health
1-10 employees
Remote behavioral health care platform analytics
Compensation Overview
$20.96 - $34.61/hr
Cranston, RI, USA
Hybrid
Hybrid work is indicated for the Cranston, Rhode Island location.
 Medical, Clinical & Veterinary (2) |
|---|
| , |
Get referred to Brown University Health
See people who can refer or advise you
- CMA or RMA certification or equivalent.
- At least 2 years of clinical healthcare experience.
- Strong communication and customer service skills.
- Excellent organization and attention to detail.
- Serve as the concierge contact for assigned patients and build long-term patient relationships.
- Communicate proactively about care plans and follow-ups.
- Coordinate referrals, imaging, laboratory tests, and specialists.
- Perform pre-visit planning and post-visit follow-up.
- Room patients and prepare examination rooms.
- Obtain and document vital signs and medical histories.
- Perform phlebotomy, electrocardiograms, injections, immunizations, and point-of-care testing.
- Assist providers during examinations and procedures.
- Manage clinical supplies.
- Manage appointment scheduling and coordinate same-day and extended visits.
- Close care gaps involving screenings, laboratory tests, and vaccinations.
- Track orders, referrals, and test results.
- Document patient interactions in the electronic health record.
- Manage medical records and referrals.
- Support onboarding of concierge members.
- Maintain compliance with the Health Insurance Portability and Accountability Act.
- Collaborate with physicians and leadership.
- Improve workflows and patient satisfaction.
- Support quality initiatives.
- Phlebotomy and electrocardiogram experience.
- Concierge or primary care experience.
- Familiarity with electronic health records and patient portals.
Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.
Company Size
1-10
Company Stage
Seed
Total Funding
$7.5M
Headquarters
New York City, New York
Founded
2018
Get referred to Brown University Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- In 2025, the AG forced Brown to add 40,000 primary-care patients by 2029.
- Brown opened a renovated primary-care site in 2026 and plans 27 new clinicians.
- A July 2026 hiring event targets advanced practice providers, signaling continued outpatient expansion.
What critics are saying
- UnitedHealthcare dropped four Brown hospitals from Medicare Advantage on July 1, 2025.
- Fiscal 2026 Q1 operating margin was negative 1.5%, while expenses rose 6.7%.
- If Brown misses 2029 primary-care commitments, Rhode Island can reopen its antitrust investigation.
What makes Brown University Health unique
- Brown University Health anchors Rhode Island's only Level I trauma center, Rhode Island Hospital.
- Its 2024 Brown affiliation deepens recruitment, research, and medical education across eight hospitals.
- Bradley Hospital and Gateway Healthcare give it rare pediatric psychiatry and community behavioral health depth.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Flexible Work Hours
Remote Work Options
Paid Vacation
Paid Holidays
Paid Sick Leave
Productivity Bonus
Stock Options
Company Equity
Conference Attendance Budget
Wellness Program
Mental Health Support
Gym Membership
Phone/Internet Stipend
Home Office Stipend
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Parental Leave
Loan Assistance
Professional Development Budget
Education allowance
Tuition Reimbursement
Professional Certification Support
Mentorship Program
Commuter Benefits
Meal Benefits
Medical Insurance
Life Insurance
Disability Insurance
Company News
LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.
PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.
PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.
PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.
DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System